| Literature DB >> 24780391 |
Sergio Rutella1, Caterina Giovanna Valentini2, Stefano Ceccarelli2, Maria Teresa Romano2, Letizia P Brescia2, Giuseppe Maria Milano2, Franco Locatelli3.
Abstract
Extracorporeal photopheresis (ECP) is broadly used in adults with cutaneous T-cell lymphoma, acute or chronic graft-versus-host disease (GVHD), rejection of solid organ transplants, and a variety of autoimmune, cell-mediated diseases. The predominant use of ECP in children and adolescents is for treating GVHD. Children pose specific challenges to ECP, due to their unique physiology and to patient's size. Herein, we will focus on current clinical trials with ECP in children with GVHD, with an emphasis on technical and clinical issues that are peculiar to the paediatric setting.Entities:
Keywords: Childhood leukemia; Graft-versus-host disease; Photopheresis; Solid organ transplantation.; Stem cell transplantation
Mesh:
Year: 2014 PMID: 24780391 DOI: 10.1016/j.transci.2014.04.004
Source DB: PubMed Journal: Transfus Apher Sci ISSN: 1473-0502 Impact factor: 1.764